Research on clinical development of a new clinical outcome (major pathological response) for preoperative treatment of lung cancer using artificial intelligence
Not Applicable
- Conditions
- on-small cell lung cancer patients who received preoperative treatment at our hospital from April 2002 to April 2021 and subsequently underwent surgery
- Registration Number
- JPRN-UMIN000047486
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
There are no specific exclusion criteria.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between PR and MPR evaluated by artificial intelligence and MPR and PR evaluated by pathologists
- Secondary Outcome Measures
Name Time Method